Atara Biotherapeutics, Inc.

DB:AT20 Stock Report

Market Cap: €43.1m

Atara Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:AT20 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Aug 24Sell€5,808Jill HenrichIndividual963€6.03
16 Aug 24Sell€6,984K. MuruganIndividual1,158€6.03
16 Aug 24Sell€6,453Eric HyllengrenIndividual1,070€6.03
16 Aug 24Sell€10,983Anhco NguyenIndividual1,821€6.03
16 Aug 24Sell€18,323Pascal TouchonIndividual3,038€6.03
22 May 24Buy€5,880,792Adiumentum Capital ManagementCompany322,636.92€18.23
16 May 24Sell€14,617Jill HenrichIndividual1,030€14.19
16 May 24Sell€16,262Eric HyllengrenIndividual1,145.92€14.19
16 May 24Sell€24,351Anhco NguyenIndividual1,715.96€14.19
16 May 24Sell€18,392K. MuruganIndividual1,296.04€14.19
16 May 24Sell€46,266Pascal TouchonIndividual3,260.24€14.19
04 Mar 24Sell€2,571Jill HenrichIndividual155.16€16.57
04 Mar 24Sell€16,469Pascal TouchonIndividual993.76€16.57
04 Mar 24Sell€4,429Eric HyllengrenIndividual267.16€16.60
04 Mar 24Sell€6,658K. MuruganIndividual401.76€16.57
04 Mar 24Sell€7,124Anhco NguyenIndividual429.84€16.57
16 Nov 23Sell€1,170Jill HenrichIndividual130.68€8.95
16 Nov 23Sell€4,282Eric HyllengrenIndividual478.32€8.95
16 Nov 23Sell€2,975K. MuruganIndividual332.28€8.95
16 Nov 23Sell€7,309Pascal TouchonIndividual816.36€8.95
16 Nov 23Sell€4,400Manher JoshiIndividual491.48€8.95
16 Nov 23Sell€3,171Anhco NguyenIndividual354.24€8.95
14 Nov 23Buy€62,853Carol GallagherIndividual10,800€7.14
10 Nov 23Buy€23,739William HeidenIndividual4,000€5.93
10 Nov 23Buy€94,976Eric DobmeierIndividual17,873€5.31

Insider Trading Volume

Insider Buying: AT20 insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of AT20?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders118,4222.41%
General Public705,87914.4%
Hedge Funds1,119,42922.8%
Institutions2,971,31960.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.5%.


Top Shareholders

Top 25 shareholders own 80.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.1%
Adiumentum Capital Management
1,133,823€9.9m251%no data
9.2%
Redmile Group, LLC
452,270€4.0m22.1%0.17%
8.27%
EcoR1 Capital, LLC
406,679€3.6m0%0.1%
5.3%
Citadel Advisors LLC
260,480€2.3m0%no data
3.78%
Bank of America Corporation, Asset Management Arm
186,001€1.6m-29.3%no data
3.45%
The Vanguard Group, Inc.
169,336€1.5m-15.6%no data
3.38%
Tavistock Life Sciences
166,000€1.5m0%0.07%
2.85%
Centiva Capital, LP
140,250€1.2m0%0.06%
2.43%
Acadian Asset Management LLC
119,370€1.0m13.1%no data
2.37%
Millennium Management LLC
116,671€1.0m707%no data
2.28%
Vestal Point Capital, LP
112,000€982.7k0%0.06%
2.09%
Qube Research & Technologies Ltd
102,663€900.8k0%no data
1.53%
Tang Capital Management, LLC
75,196€659.8k0%0.06%
1.53%
Kleiner Perkins Caufield & Byers
75,066€658.6k0%0.14%
1.44%
Woodline Partners LP
70,889€622.0k-0.15%0.01%
1.24%
BlackRock, Inc.
61,145€536.5k-77.6%no data
0.94%
Renaissance Technologies LLC
46,064€404.2k17.5%no data
0.87%
Geode Capital Management, LLC
42,677€374.5k-50.6%no data
0.81%
Staley Capital Advisers, Inc.
40,000€351.0k0%0.02%
0.75%
BNP Paribas Arbitrage Sa, Asset Management Arm
36,724€322.2k140%no data
0.74%
PGIM, Inc.
36,340€318.9k0%no data
0.71%
Medical Strategy GmbH, Asset Management Arm
35,046€307.5k-20.1%0.02%
0.64%
Northern Trust Global Investments
31,492€276.3k-7.46%no data
0.58%
Pascal Touchon
28,339€248.7k22.4%no data
0.53%
Charles Schwab Investment Management, Inc.
26,155€229.5k-14.1%no data